Modalităţi de optimizare a formelor farmaceutice cu antiinflamatoare
Modalităţi de optimizare a formelor farmaceutice cu antiinflamatoare
Modalităţi de optimizare a formelor farmaceutice cu antiinflamatoare
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
107<br />
Alvarez L, Concheiro A, Gomez-Amoza JL, Souto C, Martinez-Pacheco R.<br />
Effect of microcrystalline cellulose gra<strong>de</strong> and process variables on pellets prepared by extrusion-spheronization<br />
Drug Dev Ind Pharm. 2002; 28:451Y456<br />
124<br />
B. Boneschans, A. Wessels, J. Van Sta<strong>de</strong>n, M. Zovko, B. Zorc, J. Bergh<br />
Piroxicam benzoate - synthesis, HPLC <strong>de</strong>termination and hydrolysis<br />
Drug Develop. Ind. Pharm. 2003, 29, p. 155-160<br />
162<br />
R. K. Goel, A. Singh, M. P. Mahajan, S. K. Kulkarni<br />
Evaluation of anti inflammatory and anti hyperalgesic activity of some novel monocyclic β-lactam compounds in rats<br />
Indian J. Pharm. Sci., 2004, 66, p. 87-91<br />
169<br />
Y. N. Kalia, R. H. Guy<br />
Mo<strong>de</strong>ling trans<strong>de</strong>rma drug release<br />
Adv. Surg Delivery Rev., 2001, 48, p. 159-172<br />
173<br />
M. S. El-Ridy, R. M. Khalil<br />
Free versus liposome encapsulated lidocaine hydrochlori<strong>de</strong> topical application<br />
Pharmazie, 1999, 54, p. 682-684<br />
177<br />
R. Singh, S. P. Vyas<br />
Topical liposomal system for localized and controlled drug <strong>de</strong>livery<br />
J. Dermatol. Sci., 2006, 13, p. 107–111<br />
201<br />
B. Pose-Vilarnovo, C. Rodriguez-Tenreiro, J. F. R. dos Santos, J. Vazquez-Doval, A. Concheiro, C. Alvarez-Lorenzo and<br />
J. J. Torres-Laban<strong>de</strong>ira<br />
Modulating the drug release with cyclo<strong>de</strong>xtrins in hydroxsypropyl methylcellulose gels and tablets<br />
J. Control. Release. 2004, 94, 351-363<br />
202<br />
T. Loftsson, M. Masson<br />
Cyclo<strong>de</strong>xtrin in topical drug formulations: theory and practice<br />
Int. J. Pharm. 2001, 225, 15-30<br />
212<br />
F. Vrečer, M. Vrbinc, A. Me<strong>de</strong>n<br />
Characterization of piroxicam crystal modifications<br />
Int. J. Pharm. 2003, 256, 3-15<br />
216<br />
T. Loftsson, M. Masson<br />
The effects of water-soluble polymers on cyclo<strong>de</strong>xtrins and cyclo<strong>de</strong>xtrins solubilisation of the drugs<br />
J. Drug Del. Sci. Tech. 2004, 14, 3-20<br />
222<br />
J. M. Hill, R. J. O'Callaghan, J. A. Hob<strong>de</strong>n, E. Kaufman<br />
Controlled collagen shields for o<strong>cu</strong>lar <strong>de</strong>livery<br />
in: Ophthalmic Drug Delivery Systems<br />
(Ed. A. K. Mitra), Marcel Dekker, New York, 2003, p. 261-275<br />
234<br />
J. Balasubramaniam, J. K. Pandit<br />
In vitro characterizaton of non-<strong>de</strong>gradable scleral implants of indomethacin for prolonged o<strong>cu</strong>lar <strong>de</strong>livery<br />
Acta Pharm., 2002, 52, p. 181-188<br />
235<br />
N. J. Van Haeringen<br />
Clinical biochemistry of tears<br />
Surv. Ophthalmol., 2005, 26, p. 84-95<br />
236<br />
H. Lin, K. C. Sung<br />
Carbopol/pluronic phase change solutions for ophthalmic drug <strong>de</strong>livery<br />
J. Contr. Rel., 2000, 69, p. 379-388<br />
237<br />
M. M. Van Ooteghem<br />
in: Biopharmaceutics of O<strong>cu</strong>lar Drug Delivery<br />
(Ed. P. Edman), CRC Press, Boca Raton, 2003, p. 27-41<br />
238<br />
H. Bothner, T. Waaler, O. Wik<br />
Rheological characterization of tear substitutes<br />
Drug Dev. Ind. Pharm., 2000, 16, p. 755-768<br />
- 50 -
Change language